BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15563240)

  • 41. Palifermin: new drug. Prevention of oral mucositis: inappropriate evaluation.
    Prescrire Int; 2007 Aug; 16(90):135-8. PubMed ID: 17724832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract.
    Housley RM; Morris CF; Boyle W; Ring B; Biltz R; Tarpley JE; Aukerman SL; Devine PL; Whitehead RH; Pierce GF
    J Clin Invest; 1994 Nov; 94(5):1764-77. PubMed ID: 7962522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Keratinocyte growth factor and fibroblast growth factor action on DNA synthesis in rat and human hepatocytes: modulation by heparin.
    Strain AJ; McGuinness G; Rubin JS; Aaronson SA
    Exp Cell Res; 1994 Feb; 210(2):253-9. PubMed ID: 7507851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Palifermin for oral mucositis in the high-dose chemotherapy and stem cell transplant setting: the Royal Adelaide Hospital Cancer Centre experience.
    Keefe D; Lees J; Horvath N
    Support Care Cancer; 2006 Jun; 14(6):580-2. PubMed ID: 16775651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A protective role for keratinocyte growth factor in a murine model of chemotherapy and radiotherapy-induced mucositis.
    Borges L; Rex KL; Chen JN; Wei P; Kaufman S; Scully S; Pretorius JK; Farrell CL
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):254-62. PubMed ID: 16904525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.
    Le QT; Kim HE; Schneider CJ; Muraközy G; Skladowski K; Reinisch S; Chen Y; Hickey M; Mo M; Chen MG; Berger D; Lizambri R; Henke M
    J Clin Oncol; 2011 Jul; 29(20):2808-14. PubMed ID: 21670453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of keratinocyte growth factor in preclinical models of mucositis.
    Farrell CL; Rex KL; Chen JN; Bready JV; DiPalma CR; Kaufman SA; Rattan A; Scully S; Lacey DL
    Cell Prolif; 2002 Aug; 35 Suppl 1(Suppl 1):78-85. PubMed ID: 12139710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reliability and efficacy of palifermin in prevention and management of oral mucositis in patients with acute lymphoblastic leukemia: a randomized, double-blind controlled clinical trial.
    Lucchese A; Matarese G; Manuelli M; Ciuffreda C; Bassani L; Isola G; Cordasco G; Gherlone E
    Minerva Stomatol; 2016 Feb; 65(1):43-50. PubMed ID: 26862696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of mitogen-activated protein kinase pathway by keratinocyte growth factor or fibroblast growth factor-10 promotes cell proliferation in human endometrial carcinoma cells.
    Taniguchi F; Harada T; Sakamoto Y; Yamauchi N; Yoshida S; Iwabe T; Terakawa N
    J Clin Endocrinol Metab; 2003 Feb; 88(2):773-80. PubMed ID: 12574212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer.
    Gibson RJ; Keefe DM; Clarke JM; Regester GO; Thompson FM; Goland GJ; Edwards BG; Cummins AG
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):53-8. PubMed ID: 12111112
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions.
    Finch PW; Cunha GR; Rubin JS; Wong J; Ron D
    Dev Dyn; 1995 Jun; 203(2):223-40. PubMed ID: 7655084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Production of a 135-residue long N-truncated human keratinocyte growth factor 1 in Escherichia coli.
    Kim YS; Lee HJ; Handoko GA; Kim J; Kim SB; Won M; Park JH; Ahn J
    Microb Cell Fact; 2023 May; 22(1):98. PubMed ID: 37170276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 2002 Harry M. Vars Research Award. Keratinocyte growth factor stimulates the recovery of epithelial structure and function in a mouse model of total parenteral nutrition.
    Yang H; Wildhaber B; Tazuke Y; Teitelbaum DH
    JPEN J Parenter Enteral Nutr; 2002; 26(6):333-40; discussion 340-1. PubMed ID: 12405644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of a soluble KGF receptor cDNA from human corneal and breast epithelial cells.
    Liu JJ; Shay JW; Wilson SE
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2584-93. PubMed ID: 9856768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Keratinocyte growth factor.
    Athar U; Gentile TC
    Expert Opin Biol Ther; 2009 Jun; 9(6):779-87. PubMed ID: 19456212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis.
    Stiff PJ; Leinonen M; Kullenberg T; Rudebeck M; de Chateau M; Spielberger R
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):164-9. PubMed ID: 26303102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant.
    Nasilowska-Adamska B; Rzepecki P; Manko J; Czyz A; Markiewicz M; Federowicz I; Tomaszewska A; Piatkowska-Jakubas B; Wrzesien-Kus A; Bieniaszewska M; Duda D; Szydlo R; Halaburda K; Szczepinski A; Lange A; Hellman A; Robak T; Skotnicki A; Jedrzejczak WW; Walewski J; Holowiecki J; Komarnicki M; Dmoszynska A; Warzocha K; Marianska B
    Bone Marrow Transplant; 2007 Nov; 40(10):983-8. PubMed ID: 17846600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Keratinocyte growth factor stimulates bronchial epithelial cell proliferation in vitro and in vivo.
    Michelson PH; Tigue M; Panos RJ; Sporn PH
    Am J Physiol; 1999 Oct; 277(4):L737-42. PubMed ID: 10516214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of tumour-cell-derived or recombinant keratinocyte growth factor (KGF) on proliferation and radioresponse of human epithelial tumour cells (HNSCC) and normal keratinocytes in vitro.
    Hille A; Grüger S; Christiansen H; Wolff HA; Volkmer B; Lehmann J; Dörr W; Rave-Fränk M
    Radiat Environ Biophys; 2010 May; 49(2):261-70. PubMed ID: 20213138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.